These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 508540)

  • 1. The action of tolmesoxide on certain cardiovascular measurements in healthy human volunteers [proceedings].
    Buylla JA; Clifford JM; Wynne RD
    Br J Clin Pharmacol; 1979 Oct; 8(4):402P. PubMed ID: 508540
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular effects of intravenous tolmesoxide in hypertensive patients.
    Scheen A; Luyckx AS; De Graeve J
    Arch Int Pharmacodyn Ther; 1981 Jun; 251(2):322-34. PubMed ID: 7025775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical pharmacology of vasodilator antihypertensive drugs.
    O'Malley K; O'Boyle C; Kelly JG; McNay JL; O'Brien ET
    Arch Int Pharmacodyn Ther; 1980; Suppl():95-103. PubMed ID: 7416880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of food on the pharmacokinetics and pharmacodynamics of tolmesoxide in essential hypertensives.
    Elliott HL; Meredith PA; McLean K; Hughes MA; Reid JL
    Eur J Clin Pharmacol; 1982; 21(4):287-91. PubMed ID: 7056273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of tolmesoxide in refractory heart failure.
    O'Boyle CP; McGarry K; Fitzgerald D; Kelly JG; Horgan J; O'Malley K
    Eur J Clin Pharmacol; 1981; 21(3):169-72. PubMed ID: 7318877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolmesoxide, a drug that lowers blood pressure by a direct relaxant effect on vascular smooth muscle.
    Doxey JC
    Br J Pharmacol; 1978 May; 63(1):111-8. PubMed ID: 647155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of effects of tolmesoxide (RX71107), diazoxide, hydrallazine, prazosin, glyceryl trinitrate and sodium nitroprusside on forearm arteries and dorsal hand veins of man.
    Collier JG; Lorge RE; Robinson BF
    Br J Clin Pharmacol; 1978 Jan; 5(1):35-44. PubMed ID: 413560
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemodynamic monitoring and vasodilator therapy in acute left ventricular failure. Preliminary report on a new vasodilator, tolmesoxide.
    Mullie A; Lust P; Nievel J; Penninckx J; Vanhove L; Van Hoonacker G; Vendevelde K; Fenwick J; Coghill J
    Acta Anaesthesiol Belg; 1980; 31 Suppl():147-54. PubMed ID: 7457056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of intravenous and oral tolmesoxide.
    Lloyd-Jones JG; Henson R; Nichols JD; Greenslade D; Clifford JM
    Eur J Clin Pharmacol; 1981 Jan; 19(2):119-25. PubMed ID: 7202471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: Antihypertensive activity of a new 3-hydrazinopyridazine derivative: ISF 2123.
    Carpi C; Dorigotti L
    Br J Pharmacol; 1974 Nov; 52(3):459P. PubMed ID: 4458870
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the actions of central and peripheral administration of clonidine and BS 100-141 in the rabbit [proceedings].
    Barber ND; Reid JL
    Br J Pharmacol; 1978 Jun; 63(2):395P. PubMed ID: 667470
    [No Abstract]   [Full Text] [Related]  

  • 12. Haemodynamic effects of the multiple action antihypertensive drug urapidil.
    Mancia G
    Drugs; 1990; 40 Suppl 4():14-20; discussion 28-30. PubMed ID: 2092964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antihypertensive drugs on the hemodynamics of SHR.
    Sakai K; Kajiwara N; Koshino M; Sasaki T; Takahashi G; Kogure M; Kubota M; Yamamura A; Furukata M; Kuroda K; Ueda H; Kanmatsuse H; Sugiura F
    Jpn Heart J; 1978 Jul; 19(4):683-4. PubMed ID: 731930
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers.
    Kähönen M; Ylitalo R; Kööbi T; Turjanmaa V; Ylitalo P
    Int J Clin Pharmacol Ther; 1998 Sep; 36(9):483-9. PubMed ID: 9760009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central cardiovascular effects of flutonidine in adult fowls.
    Marmo E; Di Mezza F; Nistico G; Somma A; Ariello B; Imperatore A
    Agressologie; 1981; 22(6):269-72. PubMed ID: 7325301
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular effects of antihypertensive renomedullary lipids (APRL and ANRL).
    Muirhead EE; Folkow B; Byers LW; Aus G; Friberg P; Göthberg G; Nilsson H; Thoren P
    Acta Physiol Scand; 1983 Mar; 117(3):465-7. PubMed ID: 6880807
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular effects of KF 4307, a newly synthesized benzimidazolinone derivative, and its mechanism of action.
    Kasuya Y; Kurihara J; Kato H
    Arzneimittelforschung; 1983; 33(4):557-63. PubMed ID: 6683534
    [No Abstract]   [Full Text] [Related]  

  • 18. [Antihypertensive agents acting on the nervous system. 3: peripheral action].
    Béroniade V
    Union Med Can; 1982 Jan; 111(1):49-54. PubMed ID: 7058570
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiovascular pharmacology of a calcium antagonist antihypertensive agent, SC-30552.
    Lee JY; Rozek LF; Sanner JH; Radzialowski FM
    Methods Find Exp Clin Pharmacol; 1983; 5(4):235-49. PubMed ID: 6888086
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemodynamic effects of a new multifactorial antihypertensive drug.
    Mancia G; Ferrari AU
    Eur Heart J; 1992 Jun; 13 Suppl A():26-9. PubMed ID: 1396848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.